Beta-Blockers after myocardial infarction: returning from injured reserve - Takeaways - MDSpire

Beta-Blockers after myocardial infarction: returning from injured reserve

  • By

  • Gilles Montalescot

  • Louis Giovachini

  • Johanne Silvain

  • February 19, 2025

  • 0 min

Share

  • 1

    Beta-blockers (BB) have been debated for use in uncomplicated myocardial infarction (MI) with preserved left ventricular function.

  • 2

    The ABYSS trial indicated that interrupting BB treatment in stabilized MI patients increased rehospitalizations and mortality risk.

  • 3

    Chi et al.'s pooled analysis showed an 11% reduction in all-cause mortality associated with BB use in patients without heart failure.

  • 4

    Methodological concerns in observational studies may bias the results, highlighting the need for randomized controlled trials.

  • 5

    Patients with preserved LV function who tolerate BB should continue treatment, as stopping may have detrimental effects.

Original Source(s)

Beta-Blockers after myocardial infarction: returning from injured reserve

  • by Gilles Montalescot, Louis Giovachini, Johanne Silvain

  • February 19, 2025

Related Content

Longitudinal assessment of myocardial involvement in PASC-CVS: a single-center study from China based on multiparametric CMR

Molecular and cellular adaptations to extended hypothermic oxygenated perfusion in donation-after-circulatory-death hearts in a porcine model

Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care